Pharma-backed Mission Therapeutics stops preclinical operations, focuses on two clinical assets

Clinical-stage biotech Mission Therapeutics is closing its preclinical laboratory operations in Cambridge, UK, a spokesperson confirmed to Endpoints News.

The biotech will focus on its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

New insights into stiff-person syndrome, advancing diagnosis and treatment

Research explores the complexities of diagnosing and treating stiff-person syndrome, emphasizing the uncertain role of GAD antibodies and the promise of novel therapies.

September 5, 2024

TLT Stock & TMF Stock Analysis 5SEP23

September 6, 2023

Exclusive: CSO George Yancopoulos talks Regeneron’s next chapter of genetics, weight loss drugs, and Alzheimer’s

TARRYTOWN, NY — Thirty-five years since they founded Regeneron, the two outspoken New Yorkers atop the company are looking beyond its vaunted antibody expertise as

August 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.